SNAI1 and carcinoma: Franci et al. showed that about 77% of colon cancer samples display Snail1 immunoreactivity both in activated fibroblasts and in carcinoma cells that underwent EMT, suggesting that the presence of Snail1 immunoreactive cells may be exploited as prognostic marker in patients with colon cancer [63,64].